Boeing Is the Dow Biggest Loser While Everything Else Rips — Here Is Why It Matters

While the rest of the Dow was celebrating the Hormuz reopening like it was New Year’s Eve, Boeing was sitting in the corner nursing a drink.

BA dropped 2.34% on Thursday — the worst performer in a Dow that gained over 1,000 points. And it wasn’t just one bad day. The stock is down 14% since its last earnings report and has been trading below $220 as fresh defense-contract headlines collide with ongoing operational headaches.

The timing is almost ironic. Defense stocks should theoretically benefit from the $1.5 trillion defense budget Trump just proposed — the largest in history. The Golden Dome missile defense initiative alone will pump $17.5 billion into space-based systems in FY27. That’s Boeing’s neighborhood.

But investors aren’t buying the promise. They’re selling the execution risk.

Boeing’s commercial division is still dealing with the 737 Max production constraints that have plagued the company for years. Quality control issues haven’t disappeared — they’ve just moved from headlines to earnings calls. And the defense unit, while winning contracts, faces margin pressure from fixed-price deals signed before inflation spiked.

Meanwhile, Lockheed Martin just landed a $4.76 billion PAC-3 contract. Northrop Grumman is positioned for the Golden Dome’s OPIR satellite program. RTX is collecting hypersonic missile funding. The defense budget is flowing — it’s just flowing around Boeing, not through it.

Here’s the contrarian angle: Boeing at $219 is pricing in a lot of bad news. The company still has a $400+ billion backlog. The 737 Max production rate is slowly climbing. And the defense portfolio, while margin-compressed, has multi-decade program visibility.

The Play

Boeing is a classic “show me” stock right now. The value case is building, but there’s no catalyst to force a re-rating until production metrics improve. If you’re a patient investor, start watching the $200 support level — a break below that and you wait. A hold there with improving delivery numbers in Q2 makes BA a compelling recovery play. For now, defense exposure is better played through LMT, NOC, or RTX.